Procter & Gamble Company (The) $PG Shares Bought by Allworth Financial LP

Allworth Financial LP increased its position in Procter & Gamble Company (The) (NYSE:PGFree Report) by 20.5% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 372,932 shares of the company’s stock after buying an additional 63,317 shares during the quarter. Allworth Financial LP’s holdings in Procter & Gamble were worth $59,416,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. MOKAN Wealth Management Inc. boosted its position in shares of Procter & Gamble by 13.7% in the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company’s stock worth $2,442,000 after buying an additional 1,846 shares during the period. Benjamin Edwards Inc. lifted its position in Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company’s stock worth $62,098,000 after acquiring an additional 199,258 shares in the last quarter. Caliber Wealth Management LLC KS boosted its holdings in Procter & Gamble by 36.2% in the 2nd quarter. Caliber Wealth Management LLC KS now owns 17,798 shares of the company’s stock worth $2,836,000 after acquiring an additional 4,730 shares during the period. VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new stake in Procter & Gamble in the second quarter valued at approximately $34,684,000. Finally, First Citizens Bank & Trust Co. raised its stake in shares of Procter & Gamble by 12.8% during the second quarter. First Citizens Bank & Trust Co. now owns 156,874 shares of the company’s stock valued at $24,993,000 after purchasing an additional 17,836 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Price Performance

PG opened at $146.90 on Monday. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46. The company’s 50-day moving average price is $152.93 and its 200 day moving average price is $157.02. Procter & Gamble Company has a fifty-two week low of $144.46 and a fifty-two week high of $180.43. The firm has a market cap of $343.28 billion, a price-to-earnings ratio of 21.45, a price-to-earnings-growth ratio of 3.87 and a beta of 0.36.

Procter & Gamble (NYSE:PGGet Free Report) last issued its earnings results on Friday, October 24th. The company reported $1.99 EPS for the quarter, beating analysts’ consensus estimates of $1.90 by $0.09. The company had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a return on equity of 32.63% and a net margin of 19.74%.Procter & Gamble’s quarterly revenue was up 3.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.93 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. As a group, sell-side analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, November 17th. Shareholders of record on Friday, October 24th will be given a $1.0568 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $4.23 annualized dividend and a yield of 2.9%. Procter & Gamble’s dividend payout ratio (DPR) is currently 61.61%.

Analysts Set New Price Targets

Several brokerages have recently weighed in on PG. BNP Paribas restated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. JPMorgan Chase & Co. upped their price objective on shares of Procter & Gamble from $163.00 to $165.00 and gave the company a “neutral” rating in a research report on Monday, October 27th. Evercore ISI reaffirmed an “in-line” rating and set a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research report on Monday, July 14th. Morgan Stanley set a $175.00 price target on Procter & Gamble in a report on Monday, October 27th. Finally, BNP Paribas Exane dropped their price objective on Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating on the stock in a report on Tuesday, September 23rd. Twelve research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $171.53.

View Our Latest Report on Procter & Gamble

Insider Transactions at Procter & Gamble

In other news, CAO Matthew W. Janzaruk sold 725 shares of the business’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $149.57, for a total transaction of $108,438.25. Following the completion of the transaction, the chief accounting officer owned 979 shares of the company’s stock, valued at approximately $146,429.03. The trade was a 42.55% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction dated Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $606,788.78. Following the completion of the sale, the chief operating officer directly owned 46,899 shares in the company, valued at approximately $7,139,434.77. This trade represents a 7.83% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 150,488 shares of company stock valued at $23,529,718 over the last three months. 0.20% of the stock is currently owned by company insiders.

About Procter & Gamble

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.